Carolyn is a health care technology executive with over 20 years of leadership experience in driving the transition from fee-for-service to value-based care.

Jeremy is an epidemiologist and computer scientist with nearly 25 years of experience in the science and technology of big data.

Dorothee brings extensive experience in Epidemiology and Biostatistics. Most recently, she served as Head of Real World Evidence (RWE) and Digital Sciences at UCB Biosciences GmbH.

Priya is geneticist, biostatistician and epidemiologist by training with 20 years of experience in life science and healthcare software development.

As the chief strategy officer for Aetion, Jeremy is responsible for guiding the strategic direction of the company and for leading its corporate development activities.

Jade Cusick is the Chief Commercial Officer for Aetion. In his role, he is responsible for leading client partnerships, commercialization, and marketing for the organization across Aetion’s key customer segments and stakeholders.

Nicolle is an epidemiologist with 20 years of industry experience. She serves as a senior scientific voice ensuring appropriate and principled use of RWD and RWE, designing and communicating scientific frameworks, standards, and methodologies, and collaborating with stakeholders globally.

William is the Senior Vice President of Value-Based Solutions at Aetion, and brings over 20 years of health care experience in both payer- and provider-focused roles. Prior to Aetion, he most recently served as Chief Operations Officer for Genoa Healthcare.

Richard is Chief Growth Officer to Aetion and has led business development for several health care technology companies serving the life sciences industry.

James brings 25 years of experience leading legal and compliance teams at healthcare and technology companies. Prior to joining Aetion, James was the Chief Legal Officer at Crux Informatics, Inc., helping data-driven companies accelerate migration to the cloud.

Julie is Chief Delivery Officer at Aetion and has 17 years of experience at Pfizer working to improve overall R&D productivity.

Lowell is the Chief Legal and Regulatory Officer of Aetion. Previously, Lowell served in several senior leadership roles at the U.S. FDA, most recently as the Principal Associate Commissioner for Policy.

Sebastian is a physician and pharmacoepidemiologist with 25 years of experience in analyzing health care databases.

John brings to Aetion decades of experience leading technology teams, most recently as the first CTO of Oden Technologies, a New York-based manufacturing analytics company.

David is Chief Business Officer to Aetion, responsible for leading operations and initiatives that will accelerate Aetion’s international growth, the commercialization of its capabilities in new markets, and the Office of the CEO.

Thomas “TJ” Carella serves as a Managing Director and Head of the Healthcare Group at Warburg Pincus, based in New York.

With more than a 20-year tenure investing in young and emerging healthcare technology companies, Bill Geary serves on boards of industry-leading companies, working closely with founders and management.

Tom is an Executive, Investor and Advisor for several innovative healthcare technology businesses across the payor and provider segments.

Dr. Scott Gottlieb is a Special Partner on the NEA healthcare investment team; he was a Venture Partner at NEA from 2007 to 2017 until being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.

Mohamad Makhzoumi is a general partner at NEA and heads the firm’s Healthcare Services & Healthcare IT investment practice.

Cathy Polinsky is the Vice President of Engineering at Shopify, where she leads the company’s efforts to build its e-commerce infrastructure and scale its engineering team. She previously served as CTO of StitchFix and held leadership roles at Salesforce.